We are pleased to announce that we have been nominated for our third Bionow award.
In conjunction with Radboud University Medical Center the Apollo project will seek to establish an anti-fibrotic phototherapy for the treatment of patients with scleroderma. Scleroderma is an autoimmune disease that is characterised by an uncontrolled production of collagen that leads to pronounced skin and tissue thickening. (https://lightox.co.uk/lighting-the-way-out-of-skin-fibrosis/)
